menu search

VTYX / Ventyx Biosciences to Participate in the Barclays Global Healthcare Conference

Ventyx Biosciences to Participate in the Barclays Global Healthcare Conference
ENCINITAS, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx” or the “Company”), a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders, announced today that Raju Mohan, Chief Executive Officer of Ventyx, will provide a company overview at the Barclays Global Healthcare Conference being held March 15-17, 2022. Read More
Posted: Mar 7 2022, 08:00
Author Name: GlobeNewsWire
Views: 111499

VTYX News  

Ventyx (VTYX) Down Despite Positive Ulcerative Colitis Study Data

By Zacks Investment Research
October 11, 2023

Ventyx (VTYX) Down Despite Positive Ulcerative Colitis Study Data

Ventyx Biosciences (VTYX) announces positive top-line data from a phase II study evaluating its pipeline candidate, VTX002, for treating moderate-to-s more_horizontal

Why Shares of Ventyx Biosciences Are Dropping Tuesday

By The Motley Fool
October 10, 2023

Why Shares of Ventyx Biosciences Are Dropping Tuesday

Ventyx is a clinical-stage biotech that focuses on autoimmune disorders. The company's lead therapy candidate is VTX002 to treat moderate-to-severe ul more_horizontal

Ventyx Biosciences, Inc. (VTYX) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 13, 2023

Ventyx Biosciences, Inc. (VTYX) Q2 2023 Earnings Call Transcript

Start Time: 16:30 January 1, 0000 5:23 PM ET Ventyx Biosciences, Inc. (NASDAQ:VTYX ) Q2 2023 Earnings Conference Call August 10, 2023, 16:30 PM ET Com more_horizontal

Why Shares of Ventyx Biosciences Rose Monday

By The Motley Fool
July 3, 2023

Why Shares of Ventyx Biosciences Rose Monday

Ventyx's shares shot up while insiders were selling. The company is a clinical-stage biotech. more_horizontal

Ventyx: Critical Proof Of Concept Data Later This Year

By Seeking Alpha
June 15, 2023

Ventyx: Critical Proof Of Concept Data Later This Year

Ventyx Biosciences, Inc. has a number of interesting assets in mid-stage trials. The company is founded by a successful serial entrepreneur. Phase 2 d more_horizontal

Ventyx Biosciences, Inc. (VTYX) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 14, 2023

Ventyx Biosciences, Inc. (VTYX) Q1 2023 Earnings Call Transcript

Ventyx Biosciences, Inc. (NASDAQ:VTYX ) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ET Company Participants Raju Mohan - Founder & Chief Exe more_horizontal

Ventyx Biosciences Stock Flals Over 4%: Details

By Pulse2
March 24, 2023

Ventyx Biosciences Stock Flals Over 4%: Details

The stock price of Ventyx Biosciences Inc (NASDAQ: VTYX) fell by over 4% intraday today. This is why. more_horizontal

Ventyx Biosciences, Inc. (VTYX) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 23, 2023

Ventyx Biosciences, Inc. (VTYX) Q4 2022 Earnings Call Transcript

Ventyx Biosciences, Inc. (NASDAQ:VTYX ) Q4 2022 Earnings Conference Call March 24, 2023 4:30 PM ET Company Participants Raju Mohan - Founder & Chief E more_horizontal


Search within

Pages Search Results: